{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T01:15:00Z","timestamp":1788052500840,"version":"build-2784847793"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008549","name":"Shanxi Medical University","doi-asserted-by":"publisher","award":["CKD\/SXMU-2024-01"],"award-info":[{"award-number":["CKD\/SXMU-2024-01"]}],"id":[{"id":"10.13039\/501100008549","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019034","name":"Hubei Provincial Central Guidance Local Science and Technology Development Project","doi-asserted-by":"publisher","award":["YDZJSX20231A059"],"award-info":[{"award-number":["YDZJSX20231A059"]}],"id":[{"id":"10.13039\/501100019034","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204222"],"award-info":[{"award-number":["82204222"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022M722012"],"award-info":[{"award-number":["2022M722012"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejmech.2026.119206","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T23:34:40Z","timestamp":1786059280000},"page":"119206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design, synthesis, and biological activity of novel oxazole-based small molecule allosteric GLP-1R agonists"],"prefix":"10.1016","volume":"318","author":[{"given":"Ruifeng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoyu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuihua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengmin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119206_bib1","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.2337\/db13-1440","article-title":"Identification and characterization of GLP-1 receptor-expressing cells using a new transgenic mouse model","volume":"63","author":"Richards","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.ejmech.2026.119206_bib2","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1042\/BST20120236","article-title":"Recent advances in understanding GLP-1R (glucagon-like peptide-1 receptor) function","volume":"41","author":"Koole","year":"2013","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ejmech.2026.119206_bib3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4093\/dmj.2025.0106","article-title":"Glucagon-like Peptide-1 and hypothalamic regulation of satiation: cognitive and neural insights from human and animal studies","volume":"49","author":"Park","year":"2025","journal-title":"Diabetes & metabolism journal"},{"key":"10.1016\/j.ejmech.2026.119206_bib4","doi-asserted-by":"crossref","first-page":"E600","DOI":"10.1152\/ajpendo.00371.2023","article-title":"Class B1 GPCRs: insights into multireceptor pharmacology for the treatment of metabolic disease","volume":"327","author":"Sangwung","year":"2024","journal-title":"Am. J. Physiol. Endocrinol. Metabol."},{"key":"10.1016\/j.ejmech.2026.119206_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ajog.2024.08.024","article-title":"Glucagon-like peptide-1 receptor agonist use in pregnancy: a review","volume":"232","author":"Drummond","year":"2025","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ejmech.2026.119206_bib6","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1172\/JCI75276","article-title":"The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss","volume":"124","author":"Secher","year":"2014","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejmech.2026.119206_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118163","article-title":"Unraveling the safety profile of GLP-1 receptor agonists: mechanistic insights with a focus on semaglutide","volume":"300","author":"He","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119206_bib8","article-title":"Weight loss that lasts: reviewing the long-term impact of GLP-1 receptor agonists","volume":"17","author":"Shah","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.ejmech.2026.119206_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116471","article-title":"Peptide GLP-1 receptor agonists: from injection to oral delivery strategies","volume":"229","author":"Ke","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119206_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fddev.2026.1776167","article-title":"Oral delivery of peptides and proteins: pharmacokinetic boundaries, negative selection, and route triage","volume":"6","author":"Niazi","year":"2026","journal-title":"Frontiers in drug delivery"},{"key":"10.1016\/j.ejmech.2026.119206_bib11","doi-asserted-by":"crossref","first-page":"8208","DOI":"10.1021\/acs.jmedchem.1c01856","article-title":"A small-molecule oral agonist of the human glucagon-like Peptide-1 receptor","volume":"65","author":"Griffith","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119206_bib12","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1111\/dom.15643","article-title":"Once-daily oral small-molecule glucagon-like peptide-1 receptor agonist lotiglipron (PF-07081532) for type 2 diabetes and obesity: two randomized, placebo-controlled, multiple-ascending-dose phase 1 studies","volume":"26","author":"Buckeridge","year":"2024","journal-title":"Diabetes Obes. Metabol."},{"key":"10.1016\/j.ejmech.2026.119206_bib13","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa2302392","article-title":"Daily oral GLP-1 receptor agonist orforglipron for adults with obesity","volume":"389","author":"Wharton","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2026.119206_bib14","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/cmdc.201800699","article-title":"An overview, advantages and therapeutic potential of nonpeptide positive allosteric modulators of glucagon-like Peptide-1 receptor","volume":"14","author":"Smelcerovic","year":"2019","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2026.119206_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116632","article-title":"Binding sites and design strategies for small molecule GLP-1R agonists","volume":"275","author":"Zhang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119206_bib16","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1124\/dmd.113.052183","article-title":"Demonstration of the innate electrophilicity of 4-(3-(benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine (BETP), a small-molecule positive allosteric modulator of the glucagon-like peptide-1 receptor","volume":"41","author":"Eng","year":"2013","journal-title":"Drug Metabol. Dispos.: the biological fate of chemicals"},{"key":"10.1016\/j.ejmech.2026.119206_bib17","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1073\/pnas.0605701104","article-title":"Small-molecule agonists for the glucagon-like peptide 1 receptor","volume":"104","author":"Knudsen","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.ejmech.2026.119206_bib18","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/479505","article-title":"Berry and citrus phenolic compounds inhibit dipeptidyl peptidase IV: implications in diabetes management","volume":"2013","author":"Fan","year":"2013","journal-title":"Evid. Based Complement. Alternat. Med. : eCAM"},{"key":"10.1016\/j.ejmech.2026.119206_bib19","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1021\/acs.jmedchem.1c00029","article-title":"Discovery of an orally efficacious positive allosteric modulator of the glucagon-like Peptide-1 receptor","volume":"64","author":"Willard","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119206_bib20","doi-asserted-by":"crossref","first-page":"10192","DOI":"10.1021\/jm501375c","article-title":"Discovery of (S)-2-cyclopentyl-N-((1-isopropylpyrrolidin2-yl)-9-methyl-1-oxo-2,9-dihydro-1H-pyrrido[3,4-b]indole-4-carboxamide (VU0453379): a novel, CNS penetrant glucagon-like peptide 1 receptor (GLP-1R) positive allosteric modulator (PAM)","volume":"57","author":"Morris","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119206_bib21","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1021\/acs.jmedchem.1c01842","article-title":"Discovery of V-0219: a small-molecule positive allosteric modulator of the glucagon-like Peptide-1 receptor toward oral treatment for \"diabesity\"","volume":"65","author":"Decara","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119206_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202403179","article-title":"Review on therapeutic diversity of oxazole scaffold: an update","volume":"9","author":"Patel","year":"2024","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2026.119206_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114744","article-title":"Development of [1,2]oxazoloisoindoles tubulin polymerization inhibitors: further chemical modifications and potential therapeutic effects against lymphomas","volume":"243","author":"Barreca","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119206_bib24","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/med.22078","article-title":"Natural and synthetic 5-(3'-indolyl)oxazoles: biological activity, chemical synthesis and advanced molecules","volume":"45","author":"Liu","year":"2025","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2026.119206_bib25","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ejmech.2011.12.028","article-title":"Synthesis and anti-protozoal activity of novel dihydropyrrolo[3,4-d][1,2,3]triazoles","volume":"48","author":"D\u00fcr\u00fcst","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119206_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2024.117961","article-title":"Design, synthesis and biological evaluation of novel oxazole derivatives as potential hypoglycemic agents","volume":"114","author":"Wang","year":"2024","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119206_bib27","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1124\/mol.110.065664","article-title":"Allosteric ligands of the glucagon-like peptide 1 receptor (GLP-1R) differentially modulate endogenous and exogenous peptide responses in a pathway-selective manner: implications for drug screening","volume":"78","author":"Koole","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119206_bib28","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1021\/acs.jmedchem.4c02616","article-title":"Discovery of selenium-containing derivatives as potent and orally bioavailable GLP-1R agonists","volume":"68","author":"Chen","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119206_bib29","article-title":"Allosteric modulation of the activity of the glucagon-like peptide-1 (GLP-1) metabolite GLP-1 9-36 amide at the GLP-1 receptor","volume":"7","author":"Li","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2026.119206_bib30","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/nprot.2014.138","article-title":"The cellular thermal shift assay for evaluating drug target interactions in cells","volume":"9","author":"Jafari","year":"2014","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejmech.2026.119206_bib31","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1172\/JCI42497","article-title":"Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice","volume":"122","author":"Lamont","year":"2012","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejmech.2026.119206_bib32","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1021\/acs.jmedchem.2c02124","article-title":"Discovery of CZS-241: a potent, selective, and orally available polo-like kinase 4 inhibitor for the treatment of chronic myeloid leukemia","volume":"66","author":"Sun","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119206_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426006513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426006513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T00:17:43Z","timestamp":1788049063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426006513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":33,"alternative-id":["S0223523426006513"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119206","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and biological activity of novel oxazole-based small molecule allosteric GLP-1R agonists","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119206","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119206"}}